ATE368111T1 - Betacellulin-veränderung - Google Patents

Betacellulin-veränderung

Info

Publication number
ATE368111T1
ATE368111T1 AT99959698T AT99959698T ATE368111T1 AT E368111 T1 ATE368111 T1 AT E368111T1 AT 99959698 T AT99959698 T AT 99959698T AT 99959698 T AT99959698 T AT 99959698T AT E368111 T1 ATE368111 T1 AT E368111T1
Authority
AT
Austria
Prior art keywords
betacelluline
modification
activity
antigenicity
diabetes
Prior art date
Application number
AT99959698T
Other languages
English (en)
Inventor
Takashi Ito
Mitsuyo Kondo
Yoko Tanaka
Masayuki Kobayashi
Koichi Igarashi
Reiko Sasada
Osamu Nishimura
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE368111T1 publication Critical patent/ATE368111T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99959698T 1998-12-09 1999-12-08 Betacellulin-veränderung ATE368111T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP35037798 1998-12-09
JP5532699 1999-03-03

Publications (1)

Publication Number Publication Date
ATE368111T1 true ATE368111T1 (de) 2007-08-15

Family

ID=26396224

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99959698T ATE368111T1 (de) 1998-12-09 1999-12-08 Betacellulin-veränderung

Country Status (11)

Country Link
US (1) US6825165B1 (de)
EP (1) EP1148129B1 (de)
AT (1) ATE368111T1 (de)
AU (1) AU1681100A (de)
CA (1) CA2353909C (de)
CY (1) CY1106882T1 (de)
DE (1) DE69936666T2 (de)
DK (1) DK1148129T3 (de)
ES (1) ES2288034T3 (de)
PT (1) PT1148129E (de)
WO (1) WO2000034478A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1781322A4 (de) * 2004-08-06 2009-09-30 Novozymes Biopharma Au Ltd Verfahren zur behandlung von diabetes
EP1890722A2 (de) * 2005-05-27 2008-02-27 Five Prime Therapeutics, Inc. Verfahren und zusammensetzungen für die stimulation der glucoseaufnahme in muskelzellen, und behandlung von krankheiten
CN116323664A (zh) 2020-07-16 2023-06-23 诺华股份有限公司 抗β细胞素抗体、其片段和多特异性结合分子

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69306273T2 (de) 1992-02-10 1997-04-03 Childrens Medical Center Mitogen für die glatte Muskulatur und dessen kodierende DNS
US6410506B1 (en) * 1995-05-19 2002-06-25 Human Genome Sciences, Inc. Transforming growth factor α HII
CA2233009C (en) 1995-11-09 2005-05-10 Takeda Chemical Industries, Ltd. Composition for improving pancreatic function
JPH10191989A (ja) * 1996-11-12 1998-07-28 Takeda Chem Ind Ltd ベータセルリン類の製造方法

Also Published As

Publication number Publication date
DE69936666D1 (de) 2007-09-06
US6825165B1 (en) 2004-11-30
EP1148129A1 (de) 2001-10-24
CA2353909C (en) 2009-07-07
EP1148129B1 (de) 2007-07-25
DE69936666T2 (de) 2008-05-21
AU1681100A (en) 2000-06-26
EP1148129A4 (de) 2005-06-22
WO2000034478A1 (fr) 2000-06-15
PT1148129E (pt) 2007-09-05
DK1148129T3 (da) 2007-10-15
CY1106882T1 (el) 2012-09-26
CA2353909A1 (en) 2000-06-15
ES2288034T3 (es) 2007-12-16

Similar Documents

Publication Publication Date Title
AU1642795A (en) Substituted pyridylpyrazoles
DE69633679D1 (de) Substituierte aryl-oder heteroarylamide mit retinoid-ähnlicher biologischer aktivität
DE69839279D1 (de) Neue physiologisch aktive substanz sulphostin, herstellung und verwendung derselben
DE60121988D1 (de) Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln
DE60231295D1 (de) R und ppar modulatoren
FI964314A7 (fi) Substituoidut sulfonamidit selektiivisinä beta3-agonisteina diabeteksen ja liikalihavuuden hoitoon
NO20063000L (no) Kombinasjon og farmasøytisk blanding for behandling av diabetes samt anvendelse derav.
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
EP1001782A4 (de) 5,6-HETEROARYL-DIPYRIDO (2-3-b:3',2'-f) AZEPINE UND DEREN VERWENDUNG ZUR PROPHYLAXE UND BEHANDLUNG VON HIV-INFEKTIONEN
ATE257844T1 (de) Menschlicher wachstumsfaktor (hgf), verändert durch polyethylenglykol
DE69021383D1 (de) Medizinisches beatmungsgerät.
ATE174221T1 (de) Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
ITRM930291A0 (it) Procedimento per la preparazione di biopolimeri iodurati con attivita'disinfettante e cicatrizzante, e biopolimeri iodurati cosi' ottenuti.
DK0556322T3 (da) Aminosulfonylurinstof-ACAT-inhibitorer
CY1106882T1 (el) Τροποποιηση βητακυτταρουλινης
ATE250021T1 (de) Hydroxycyclopentanone
AU3401093A (en) Therapeutic agent for threatened abortion
DE69003712D1 (de) Optisch aktive Verbindungen, ihre Herstellung und Verwendung.
ES2152315T3 (es) Xamoneline tartrato.
AU6309398A (en) Agent for preventing and/or treating cachexia
DK0579939T3 (da) Phospholipidderivater
ATE165594T1 (de) Triarylethylenderivate zur therapeutischen verwendung
DK0673913T3 (da) Calcium-alkalimetalcitratforbindelser samt deres anvendelse som lægemidler
DE59104129D1 (de) 2,2'-Thienyl-benzothiophene, ihre Herstellung und ihre Verwendung zur Bekämpfung von Schädlingen.
IT8622051A1 (it) Composizioni farmaceutiche ad attivita' cicatrizzante

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1148129

Country of ref document: EP

REN Ceased due to non-payment of the annual fee